Chemours, DuPont Settle 2,600+ Plaintiff PFAS Lawsuit

CLIFF NOTES

• Chemours, DuPont and 2,658 North Carolina plaintiffs settled before trial.
• The residents alleged that GenX and other PFAS contaminated private wells and property.
• The settlement terms and payment amounts were not publicly disclosed.
• Separate utility lawsuits and a proposed $450 million federal Chemours agreement remain active issues.
• Reverse osmosis and certified PFAS filters can reduce exposure, while standard water softeners are not designed specifically for PFAS.

 

A major North Carolina PFAS lawsuit settlement has ended before a jury could hear the case. Chemours, DuPont and 2,658 plaintiffs reached an out-of-court agreement over contamination tied to the Fayetteville Works chemical plant. The settlement resolves the residents’ claims, but its financial terms and other conditions have not been made public.

What happened in the North Carolina PFAS lawsuit?

For eight years, Mike Watters and thousands of other North Carolina residents waited for their claims against Chemours and DuPont to reach a courtroom.

Watters lives in Grays Creek, near the Chemours Fayetteville Works plant. He was one of 2,658 plaintiffs who alleged that GenX and other per- and polyfluoroalkyl substances, or PFAS, had contaminated the Cape Fear River, groundwater, soil, air and private drinking-water wells.

The trial was expected to begin in federal court in Raleigh. Instead, the parties reached a settlement before opening arguments could proceed.

“I wanted to see it go to trial,” Watters said. “I would have liked to have seen how a jury would have handled it.”

The agreement covers all 2,658 plaintiffs. Attorneys had not disclosed the settlement amount or its detailed terms when the agreement was announced. The case was a consolidated action, not a class-action lawsuit.

What did the plaintiffs claim?

The residents alleged that releases from Fayetteville Works damaged their homes, their ability to use their property and their sense of security about their health.

They sought compensation for several claimed harms:

• Lower property values.
• Loss of full use and enjoyment of their land.
• Emotional distress related to possible health effects.
• Contamination of private drinking-water wells.

Chemours now operates Fayetteville Works. DuPont owned the facility before Chemours was separated from the company in 2015.

The plaintiffs’ lawyers, Brett Land and Cary McDougal of Baron & Budd, described the settlement as a favorable result.

“We are pleased to report that we have made significant progress in resolving our clients’ claims in a way that will compensate them for the impact of PFAS chemicals from the Fayetteville Works Plant to their lives and property,” the attorneys said. “We believe this is an extremely positive and successful outcome on behalf of our clients.”

A Chemours spokesperson declined to comment on the case. The attorneys did not identify which side first proposed settlement negotiations.

Why did the case matter beyond the 2,658 plaintiffs?

The proceeding was expected to function as a bellwether trial.

A bellwether trial is a test case used to show how a jury may respond to evidence, legal arguments and damages claims that appear in a larger group of related lawsuits. Its verdict does not automatically decide every other case, but it can influence later negotiations and litigation strategy.

For Chemours, DuPont and the affected residents, the first verdict could have changed the balance of power.

A substantial plaintiff victory might have encouraged more claims or larger settlement demands. A defense verdict could have weakened similar cases. By settling before trial, both sides avoided that uncertainty.

The agreement also prevented residents from hearing company officials testify publicly about the contamination and the companies’ past knowledge of chemical releases.

For Watters, that lost opportunity carried personal weight. He had expected that he might finally be able to face company representatives in court and describe how PFAS contamination had affected his family and property.

What are GenX and PFAS?

PFAS are a large family of synthetic chemicals valued for their resistance to water, grease, stains and heat.

They have been used in nonstick coatings, industrial processes, firefighting foam, food packaging, textiles and water-resistant consumer goods.

GenX is the trade name associated with a chemical process developed as a replacement for PFOA, an older PFAS compound. Like other PFAS, GenX-related chemicals can remain in water and the environment for long periods.

The original report described roughly 15,000 PFAS compounds. Federal agencies and researchers continue to examine the risks and behavior of different chemicals within that broad group.

What health concerns are linked to PFAS exposure?

Scientific studies have associated exposure to certain PFAS with several health effects, including kidney and testicular cancer, thyroid problems, reproductive effects, reduced birth weight and changes to immune function.

Not every PFAS compound has been studied to the same degree. Risk can also depend on the chemical, exposure level, exposure route and length of exposure.

Chemours has disputed claims connecting chemicals from its operations to the health effects alleged by residents.

Watters said the contamination had become more than a dispute over land or money. He and members of his family had participated in studies that measured PFAS in their blood.

“I know the chemicals affected more than just my property,” he said. “I know what’s in my body, and the bodies of my wife, dog and son.”

How did contamination spread from Fayetteville Works?

Court records and state investigations have described several routes by which chemicals from Fayetteville Works entered the surrounding environment.

Wastewater discharges carried chemicals toward the Cape Fear River. Air emissions also released compounds from the facility’s stacks.

According to state environmental findings described in the litigation, some airborne compounds mixed with atmospheric moisture and later deposited onto land. Those chemicals then moved through soil and groundwater, contributing to contamination in private wells.

The consolidated lawsuit covered 17 chemicals detected in wells near the plant.

Previously sealed court records also addressed disclosures made by DuPont before Chemours took control of the site.

The records stated that DuPont failed to disclose fluoromalonate in the plant’s wastewater in 2002. Fluoromalonate is not classified as a PFAS, but court documents described it as a toxic compound of concern.

An EPA complaint also alleged that DuPont failed to provide complete information in 2008 about environmental releases of GenX and possible worker exposure.

Other records alleged that DuPont reassured the North Carolina Department of Environmental Quality that GenX would not be released from one manufacturing area while failing to disclose releases of GenX and related precursor compounds from another part of the plant.

What other PFAS cases does Chemours face?

The North Carolina residents’ settlement is one part of a much larger legal struggle.

Chemours has faced PFAS litigation in several states, including New Jersey and Ohio. Its corporate filings have also reported substantial liabilities connected to PFAS disputes and environmental claims.

Public water providers in North Carolina have separately sued Chemours and DuPont over contamination affecting drinking-water systems. Those utility cases are legally distinct from the consolidated action involving Watters and the other residents.

The company has also reached major agreements in other jurisdictions. In 2025, Chemours, DuPont and Corteva agreed to pay New Jersey a combined $875 million over 25 years to resolve environmental claims, including PFAS-related allegations.

How does the private settlement differ from the federal Chemours agreement?

The residents’ settlement should not be confused with a separate proposed federal agreement announced in June 2026.

Under that agreement, Chemours would resolve federal claims involving PFAS releases and environmental violations at facilities in North Carolina, West Virginia and New Jersey.

The proposed package is valued at about $450 million. It includes a $22.5 million civil penalty, approximately $90 million for additional mitigation programs and hundreds of millions of dollars in pollution controls and drinking-water measures.

Chemours has denied violating the laws listed in the federal agreement while agreeing to its terms.

Principal Deputy Assistant Attorney General Adam Gustafson of the Justice Department’s Environment and Natural Resources Division said:

“Through this commitment, Chemours will better control PFAS at its plants, allowing the company to continue its manufacturing operations while protecting communities in North Carolina, West Virginia, and New Jersey from PFAS exposure. This agreement ensures that the company will manufacture these critical materials in a responsible manner.”

The federal settlement addresses only certain chemicals and alleged violations. Sampling around Fayetteville Works has identified many more PFAS compounds in plant discharges, public water supplies and private wells.

Why have North Carolina officials criticized the federal agreement?

North Carolina leaders and environmental advocates have argued that the proposed federal settlement provides too little direct relief for communities around Fayetteville Works.

North Carolina Attorney General Jeff Jackson said state officials were not adequately consulted before the agreement was announced.

He called the deal “an insult to the people of eastern North Carolina. Our state is ground zero for GenX contamination, but this deal does practically nothing to clean up our water.”

Critics have also objected to provisions that would resolve listed federal claims and restrict future federal enforcement over the same alleged violations.

Jean Zhuang, a senior attorney with the Southern Environmental Law Center, said affected communities should be angered by the outcome.

“The communities that have been impacted by this company’s toxic pollution should be infuriated that Chemours is getting away with this,” Zhuang said. “After decades of research on how much they’ve destroyed the air and drinking water and soil and rivers and all of these communities, the company is fighting tooth and nail to shield itself. It has no intent to protect the community.”

Chemours and federal officials have defended the broader agreement as a way to secure pollution controls, civil penalties and drinking-water investments while allowing continued manufacturing under stricter conditions.

What is happening to federal PFAS drinking-water rules?

The settlement arrives during a period of changing federal PFAS policy.

The EPA has proposed withdrawing federal drinking-water limits for GenX and two other PFAS compounds that were included in standards adopted under the Biden administration.

That proposed change has increased the importance of state enforcement, private lawsuits and court-supervised settlements for communities seeking cleanup or compensation.

The original report also noted that EPA Administrator Lee Zeldin appointed Chemours officials Shawn Gannon and Sean Uhl to the agency’s Science Advisory Board. Both men had worked on projects connected to Fayetteville Works and appeared in court records related to the public-utility litigation.

How does the settlement affect residents?

The immediate effect is clear: the plaintiffs will not receive a public jury verdict.

Instead, their claims will be resolved under confidential or undisclosed settlement terms. Depending on the final agreement, residents may receive compensation without facing the delay, cost and uncertainty of a full trial and possible appeals.

The tradeoff is silence.

The public may never hear all the evidence that would have been presented. Company officials may not be questioned in open court. A jury will not issue findings about responsibility or damages.

The settlement resolves one legal battle, but it does not end the larger questions surrounding PFAS contamination in southeastern North Carolina.

Private wells remain a concern. Public utilities continue to pursue separate claims. Regulators are still confronting dozens of chemicals associated with the plant. Residents continue to live with uncertainty over exposure, property values and long-term cleanup.

Can reverse osmosis reduce PFAS in drinking water?

Reverse osmosis systems can reduce many PFAS compounds in household drinking water when the system is properly selected, certified and maintained.

Reverse osmosis forces water through a membrane that separates many dissolved contaminants from the treated water. The EPA identifies reverse osmosis, granular activated carbon and specialized ion-exchange media as technologies that can significantly reduce PFAS under appropriate operating conditions.

Homeowners should look for a system with a verified PFAS-reduction claim, including applicable NSF/ANSI certification. Filters and membranes must be replaced on schedule. No treatment system should be assumed to remove every PFAS compound at every concentration.

Testing the untreated water remains important because treatment should be matched to the contaminants actually present.

How do whole-home water conditioners relate to PFAS?

A standard whole-home water conditioner or softener is mainly designed to reduce hardness minerals such as calcium and magnesium. It should not automatically be treated as a PFAS-removal system.

Some whole-home treatment systems can include activated carbon or specialized ion-exchange media designed for certain contaminants. Their performance depends on the media, water chemistry, flow rate, contaminant levels and maintenance schedule.

In a home affected by both hard water and PFAS, the systems may serve different purposes. A water conditioner can address scale and hardness, while a certified reverse osmosis or PFAS-specific filtration system can provide additional treatment for drinking and cooking water.

For residents in Virginia and North Carolina, laboratory water testing can help determine whether a property needs hardness treatment, contaminant reduction or a combination of systems.

The End Of An 8 Year Wait

The North Carolina PFAS lawsuit settlement ends an eight-year legal wait for 2,658 residents, but it does not close the wider conflict over Fayetteville Works.

The plaintiffs may receive compensation without enduring a long trial. Chemours and DuPont avoid the uncertainty of a jury verdict. The public, however, loses a rare opportunity to hear the full case tested in open court.

The settlement resolves claims. It does not remove PFAS from wells, answer every health question or settle the future of federal regulation.

For affected households, the central issue remains unchanged: knowing what is in the water, understanding the source and choosing treatment based on verified test results.Source: Inside Climate News